In this episode of Making Markets, host Daniel Newman digs deeper into the evolution of the Twitter and Elon Musk saga. Musk has now put Twitter into an interesting juxtaposition and Twitter’s board decided to enact a poison pill strategy. Let's explore the pros and cons of the deal, why Twitter’s board should bring the vote to shareholders, and more.